Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用
基本信息
- 批准号:10251255
- 负责人:
- 金额:$ 42.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive Cell TransfersCD8-Positive T-LymphocytesCancer PatientCell physiologyCellsCellular Metabolic ProcessCholesterolClinicalColon CarcinomaColonic NeoplasmsCytotoxic T-LymphocytesHumanImmuneImmunotherapyIn complete remissionMalignant NeoplasmsMetabolicMethodsModelingMultiple MyelomaMusNivolumabNormal tissue morphologyPD-1/PD-L1PatientsRoleSamplingT-LymphocyteTestingToxic effectTumor TissueTumor-Derivedanti-PD1 antibodiesantitumor effectbasecancer immunotherapycancer therapyclinical efficacycytotoxic CD8 T cellseffector T cellexhaustexhaustionimmune checkpoint blockadeimprovedmelanomaneoplastic cellnew therapeutic targetnovelphase 1 studyprogrammed cell death ligand 1programmed cell death protein 1receptorresponsesuccesstherapeutic developmenttumortumor microenvironment
项目摘要
Project Summary
Recently we discovered that cholesterol metabolically reprograms tumor-infiltrating T cells so that they
become exhausted. Our unpublished, preliminary studies showed that tumor tissues have a much higher
cholesterol content compared with normal tissues, and the PD-1high2B4high CD8+ T cells in tumor-infiltrating T
cells have significantly higher cholesterol content than PD-1med2B4med cells, which in turn have significantly
higher cholesterol content than PD-1low2B4low cells in different murine tumor models. The same was observed
in human multiple myeloma and colon tumor samples of. We also showed that the PD-1high2B4high CD8+ T cells
have significantly higher LAG-3 and TIM-3 (other T-cell exhaustion markers) expression than PD-1med2B4med
cells, and the PD-1med2B4med cells have significantly higher LAG-3 and TIM-3 expression than PD-1low2B4low
cells. Consistently, sorted PD-1high2B4high CD8+ T cells displayed much weaker cytolytic activity against target
tumor cells than PD-1med2B4med CD8+ T cells. Adding cholesterol to the culture of tumor-specific CD8+ T cells
upregulated their expression of PD-1 and other exhaustion markers and reduced their cytolytic activity.
Conversely, reducing cholesterol content in sorted PD-1high2B4high tumor-infiltrating CD8+ T cells downregulated
their expression of PD-1 and other exhaustion markers and enhanced their cytolytic activity. Based on these
novel findings, we hypothe size that the tumor and its microenvironment induce effector T -cell exhaustion by
using cholesterol to metabolically reprogram and upregulate the expression of immune inhibitory receptors and
exhaustion markers on CD8+ cells. Aim 1 will determine the mechanisms underlying cholesterol-induced CD8+
T-cell exhaustion, and Aim 2 will reprogram CD8+ T-cell metabolism and/or the tumor microenvironment to
enhance the antitumor effects of tumor-specific CD8+ T cells. Completing this project will give us in-depth
understanding of the mechanisms involved in how tumor -derived cholesterol metabolically repr ograms tumor-
infiltrating T cells so that they become exhausted. Understanding the mechanisms will allow us and others to
identify novel therapeutic targets and develop new methods to improve the efficacy of T cell- or immune
checkpoint blockade-based immunotherapy in cancer.
项目摘要
最近,我们发现胆固醇代谢对肿瘤浸润的T细胞进行重新编程,以便它们
变得精疲力尽。我们未发表的初步研究表明,肿瘤组织的较高
与正常组织相比,胆固醇含量,以及肿瘤浸润T的PD-1HIGH2B4-HIGH CD8+ T细胞
细胞的胆固醇含量明显高于PD-1Med2B4Med细胞,而PD-1Med2B4Med细胞又具有显着的
在不同的鼠肿瘤模型中,胆固醇含量高于PD-1LOW2B4LOW细胞。观察到一样
在人类多发性骨髓瘤和结肠肿瘤样品中。我们还表明PD-1HIGH2B4高CD8+ T细胞
与PD-1Med2B4Med相比,LAG-3和TIM-3(其他T细胞耗尽标记)的表达明显更高
细胞,PD-1Med2B4Med细胞的滞后3和TIM-3表达明显高于PD-1LOW2B4LOW
细胞。一致地,分类的PD-1HIGH2B4HIGH CD8+ T细胞显示出针对靶的细胞溶解活性较弱
肿瘤细胞比PD-1Med2B4Med CD8+ T细胞。将胆固醇添加到肿瘤特异性CD8+ T细胞的培养物中
上调了它们的PD-1和其他精疲力尽标记,并降低了其溶溶活性。
相反,在排序的PD-1HIGH2B4HIGH肿瘤渗透CD8+ T细胞中降低胆固醇含量下调
它们的PD-1和其他疲惫标记物的表达并增强了其细胞溶解活性。基于这些
新发现,我们假设肿瘤及其微环境通过
使用胆固醇代谢重新编程并上调免疫抑制受体的表达和
CD8+细胞上的耗尽标记。 AIM 1将确定胆固醇诱导的CD8+的机制
T细胞耗尽,AIM 2将重新编程CD8+ T细胞代谢和/或肿瘤微环境至
增强肿瘤特异性CD8+ T细胞的抗肿瘤作用。完成该项目将使我们深入
了解肿瘤衍生的胆固醇如何代谢肿瘤涉及的机制
渗透T细胞,使它们筋疲力尽。了解这些机制将使我们和其他人得以
确定新型的治疗靶标并开发新方法以提高T细胞或免疫的功效
基于检查点封锁的癌症免疫疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qing Yi其他文献
Qing Yi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qing Yi', 18)}}的其他基金
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
分泌IL-9的Tc9细胞诱导肿瘤焦亡的新机制
- 批准号:
10704861 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Role of lipid metabolism in CD8+ T cell ferroptosis
脂质代谢在 CD8 T 细胞铁死亡中的作用
- 批准号:
10792062 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用
- 批准号:
10673683 - 财政年份:2019
- 资助金额:
$ 42.55万 - 项目类别:
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用
- 批准号:
10456222 - 财政年份:2019
- 资助金额:
$ 42.55万 - 项目类别:
Role of MIF in myeloma bone homing and drug response
MIF 在骨髓瘤骨归巢和药物反应中的作用
- 批准号:
9211149 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
- 批准号:
9634041 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
- 批准号:
10091406 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
- 批准号:
9283894 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
Role of MIF in myeloma bone homing and drug response
MIF 在骨髓瘤骨归巢和药物反应中的作用
- 批准号:
10078263 - 财政年份:2017
- 资助金额:
$ 42.55万 - 项目类别:
A novel T-cell subset able to kill relapsed cancers
一种能够杀死复发癌症的新型 T 细胞亚群
- 批准号:
9291443 - 财政年份:2016
- 资助金额:
$ 42.55万 - 项目类别:
相似国自然基金
肺部IFN-γ通过上调CXC趋化因子募集Th1与CD8阳性T淋巴细胞的作用及机制研究
- 批准号:81970013
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10764143 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Next generation T cell therapies for mutant KRAS solid tumors
针对突变 KRAS 实体瘤的下一代 T 细胞疗法
- 批准号:
10731929 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别:
Microfluidic technology to isolate tumoricidal T-cells from peripheral blood
微流控技术从外周血中分离杀肿瘤T细胞
- 批准号:
10613173 - 财政年份:2023
- 资助金额:
$ 42.55万 - 项目类别: